Price (delayed)
$51.9
Market cap
$8.14B
P/E Ratio
62.53
Dividend/share
$0.32
EPS
$0.83
Enterprise value
$8.42B
Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.